Panagora Asset Management Inc Neurocrine Biosciences Inc Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 7,257 shares of NBIX stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,257

Previous 7,646 5.09%

Holding current value

$1.01 Million

Previous $1.05 Million 20.63%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $44,571 - $59,575	-389 Reduced 5.09%	7,257 $835,000
Q2 2024 Jul 29, 2024	SELL	$130.86 - $143.19 $34 Million - $37.2 Million	-259,951 Reduced 97.14%	7,646 $1.05 Million
Q1 2024 May 07, 2024	BUY	$130.4 - $143.74 $25.7 Million - $28.4 Million	197,249 Added 280.39%	267,597 $36.9 Million
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $4.91 Million - $6.14 Million	46,245 Added 191.86%	70,348 $9.27 Million
Q3 2023 Oct 31, 2023	BUY	$94.02 - $117.1 $756,672 - $942,420	8,048 Added 50.13%	24,103 $2.71 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $473,613 - $554,762	5,290 Added 49.14%	16,055 $1.51 Million
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $19,198 - $25,096	-204 Reduced 1.86%	10,765 $1.09 Million
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $271,068 - $322,732	-2,540 Reduced 18.8%	10,969 $1.31 Million
Q4 2021 Feb 10, 2022	SELL	$79.65 - $106.22 $100,677 - $134,262	-1,264 Reduced 8.56%	13,509 $1.15 Million
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $9,393 - $10,794	-109 Reduced 0.73%	14,773 $1.42 Million
Q2 2021 Aug 11, 2021	BUY	$89.43 - $102.27 $412,182 - $471,362	4,609 Added 44.87%	14,882 $1.45 Million
Q1 2021 May 12, 2021	BUY	$87.57 - $119.4 $356,147 - $485,599	4,067 Added 65.53%	10,273 $999,000
Q4 2020 Feb 10, 2021	SELL	$86.91 - $108.33 $11,559 - $14,407	-133 Reduced 2.1%	6,206 $595,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $581,671 - $817,522	6,049 Added 2085.86%	6,339 $610,000
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $4,935 - $7,560	58 Added 25.0%	290 $35,000
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $17,425 - $26,392	232 New	232 $20,000
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $75,438 - $91,350	-900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $43,173 - $55,152	900	900 $55,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Neurocrine Biosciences Inc Transaction History